Artículos de revistas sobre el tema "B. E. Robuck, Inc"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "B. E. Robuck, Inc".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Bartolome, Amelita, Anna Almazan, Salina Abusali, Stanley Tam, Eric Lee, Amogh Changavi, Wendy Trinh et al. "1089. Analytical Performance of an Ultrasensitive Immunoassay for Detection of Clostridium difficile Toxins in Stool". Open Forum Infectious Diseases 5, suppl_1 (noviembre de 2018): S326. http://dx.doi.org/10.1093/ofid/ofy210.924.
Texto completoGomperts, Edward D., Shashikant Apte, Utpal Chaudhuri, Joseph M. John, Vijay Ramanan, Ri Liesner, Amy D. Shapiro, Bonnie J. Mills y Martin Lee. "IB1001, an Investigational Recombinant Factor IX, Pharmacokinetics in Pediatric Patients with Hemophilia B." Blood 120, n.º 21 (16 de noviembre de 2012): 2225. http://dx.doi.org/10.1182/blood.v120.21.2225.2225.
Texto completoKarasiewicz, Kathy, Shuyang He, Mary Ng, Kristina Tess, Weifang Ling, Gunnar F. Kaufmann, Jerome B. Zeldis, Henry Ji, Robert Hariri y Xiaokui Zhang. "Preclinical Evaluation of Human Placental-Derived Allogeneic CD19 CAR-T Cells Against B Cell Malignancies". Blood 134, Supplement_1 (13 de noviembre de 2019): 3222. http://dx.doi.org/10.1182/blood-2019-130782.
Texto completoCoyne-Beasley, Tamera, Joseph Bocchini, Alejandro Cane, Cindy Burman, Maria J. Tort y Jessica Presa. "01. Serum Bactericidal Activity Against Circulating and Reference Strains of Meningococcal Serogroup B in the United States: A Review of Meningococcal Serogroup B (MenB) Vaccines in Adolescents and Young Adults". Open Forum Infectious Diseases 8, Supplement_1 (1 de noviembre de 2021): S124—S125. http://dx.doi.org/10.1093/ofid/ofab466.204.
Texto completoLasater, Elisabeth A., An D. Do, Luciana Burton, Yijin Li, Erin Williams, Jason Oeh, Luciana Molinero et al. "Resistance of Natural Killer and T Cells to Venetoclax Allows for Combination Treatment with Cancer Immunotherapy Agents". Blood 132, Supplement 1 (29 de noviembre de 2018): 1118. http://dx.doi.org/10.1182/blood-2018-99-116405.
Texto completoHe, Jie, Jose A. Bufill, Michelle K. Nahas, Kai Wang, Lauren E. Young, Kristina M. Knapp, Kristina W. Brennan et al. "Clinical Utility of Comprehensive Profiling of Genomic Alterations in Hematologic Malignancies". Blood 124, n.º 21 (6 de diciembre de 2014): 1072. http://dx.doi.org/10.1182/blood.v124.21.1072.1072.
Texto completoGe, Jianning, Chunhui Yang, Jing Sun, Jiao Chen, Shuyi Qiu, Wenjie Yin, Lianjun Shen, Martina Sersch, Wei Cao y Xinxin Wang. "Preclinical Results of an Allogeneic, Universal CD19/CD7-Targeting CAR-T Cell Therapy (GC502) for B Cell Malignancies". Blood 138, Supplement 1 (5 de noviembre de 2021): 1722. http://dx.doi.org/10.1182/blood-2021-148500.
Texto completoLilley, Graham, Alden Ladd, Daniel Cossette, Laura Viggiano, Gregory Hopkins, John W. Evans, Mingli Li et al. "Characterization of Lentiviral Vector Derived Anti-Bcma CAR T Cells Reveals Key Parameters for Robust Manufacturing of Cell-Based Gene Therapies for Multiple Myeloma". Blood 126, n.º 23 (3 de diciembre de 2015): 3243. http://dx.doi.org/10.1182/blood.v126.23.3243.3243.
Texto completoTran, Thai Hong, Krupa Scott, Shyun-Shyun Lee, Reshma Singh, Shawn Cogan, Jennifer Bordeaux, Hummel Jennifer et al. "Quantitative Multiplexed Immunohistochemistry Assays for Exploring CAR Modified T Cells and Checkpoint Inhibitors in Lymphoma Trials". Blood 126, n.º 23 (3 de diciembre de 2015): 2659. http://dx.doi.org/10.1182/blood.v126.23.2659.2659.
Texto completoTotman, Jennifer, Dorothy Brach, Vinny Motwani, Selene Howe, Emily Deutschman, John Lampe, Thomas V. Riera et al. "Pharmacologic Inhibition of the Histone Methyltransferase SETD2 with EZM0414 As a Novel Therapeutic Strategy in Relapsed or Refractory Multiple Myeloma and Diffuse Large B-Cell Lymphoma". Blood 138, Supplement 1 (5 de noviembre de 2021): 1142. http://dx.doi.org/10.1182/blood-2021-151147.
Texto completoSchomer, Nathan Thomas, Laurent Boissel, Karen Jiang, Hans Klingemann, John H. Lee y Patrick Soon-Shiong. "Providing a Homing Receptor for CAR Engineered NK Cells - Improving Cellular Immunotherapy for B-Cell Lymphoma". Blood 132, Supplement 1 (29 de noviembre de 2018): 4547. http://dx.doi.org/10.1182/blood-2018-99-116890.
Texto completoChang, Kai-Hsin, Minerva Sanchez, Jack Heath, Edouard deDreuzy, Scott Haskett, Abigail Vogelaar, Kiran Gogi et al. "Comparative Studies Reveal Robust HbF Induction By Editing of HBG1/2 Promoters or BCL11A Erythroid-Enhancer in Human CD34+ Cells but That BCL11A Erythroid-Enhancer Editing Is Associated with Selective Reduction in Erythroid Lineage Reconstitution in a Xenotransplantation Model". Blood 132, Supplement 1 (29 de noviembre de 2018): 409. http://dx.doi.org/10.1182/blood-2018-99-114780.
Texto completoCampbell, Veronica, Ryan Thompson, Vivian Villegas, Jennifer Proctor, Karen McGovern, Jeffery L. Kutok y Howard M. Stern. "The Potent PI3K-δ,γ Inhibitor IPI-145 Exhibits Differential Activity In Diffuse Large B-Cell Lymphoma (DLBCL) Cell Lines". Blood 122, n.º 21 (15 de noviembre de 2013): 1832. http://dx.doi.org/10.1182/blood.v122.21.1832.1832.
Texto completoToudjarska, Ivanka, Zuhua Cai, Tim Racie, Julia Hettinger, Stuart Milstein, Brian R. Bettencourt, Dinah WY Sah, David Bumcrot, John Maraganore y Akshay Vaishnaw. "RNAi-Mediated Inhibition of Activated Protein C- A New Approach for Hemophilia Treatment". Blood 118, n.º 21 (18 de noviembre de 2011): 1204. http://dx.doi.org/10.1182/blood.v118.21.1204.1204.
Texto completoStorhoff, James, Brett Wallden, Rita M. Braziel, Catherine Thieblemont, Tressa Hood, Harini Ravi, Shannon Dennis et al. "Analytical Performance of Nanostring's Companion Diagnostic (CDx) Lymphoma Subtyping Test (LST) with Diffuse Large B-Cell Lymphoma Core Needle Biopsy Samples". Blood 126, n.º 23 (3 de diciembre de 2015): 1481. http://dx.doi.org/10.1182/blood.v126.23.1481.1481.
Texto completoCoiffier, Bertrand, Juan-Manuel Sancho, Wojciech Jurczak, Jin Seok Kim, Raj V. Nagarkar, Edvard Zhavrid, Jose Angel Hernandez Rivas et al. "Pharmacokinetic and Safety of CT-P10, a Biosimilar Candidate to the Rituximab Reference Product, in Patients with Newly Diagnosed Advanced Stage Follicular Lymphoma (AFL)". Blood 128, n.º 22 (2 de diciembre de 2016): 1807. http://dx.doi.org/10.1182/blood.v128.22.1807.1807.
Texto completoGanesan, Harish, Vipul Kumar, Sujata M. Bhavnani, David Melnick y Christopher M. Rubino. "1105. Population Pharmacokinetic Analyses for Tebipenem After the Administration of Tebipenem Pivoxil Hydrobromide". Open Forum Infectious Diseases 8, Supplement_1 (1 de noviembre de 2021): S644—S645. http://dx.doi.org/10.1093/ofid/ofab466.1299.
Texto completoMerrill, J. T., J. Guthridge, D. Zack, P. Foster, B. Burington, L. Tran, M. Smith y J. A. James. "SAT0187 DISCRIMINATION OF SYSTEMIC LUPUS (SLE) PATIENTS WITH CLINICAL RESPONSE TO OBEXELIMAB (XMAB®5871) BASED ON A PATTERN OF IMMUNOLOGIC MARKERS". Annals of the Rheumatic Diseases 79, Suppl 1 (junio de 2020): 1035–36. http://dx.doi.org/10.1136/annrheumdis-2020-eular.2972.
Texto completoDias, Lizalynn, Venkata Thodima, Geetu Mendiratta, Guttapalli Asha, Camille Gonzalez, Jocelyn C. Maragulia, Andrew D. Zelenetz, Julie Teruya Feldstein, Raju S. K. Chaganti y Jane Houldsworth. "Cross-Platform Assessment Of Genomic Imbalance In Diffuse Large B-Cell Lymphoma Identifies Novel Candidate Loci and Genes With Prognostic Value and Roles In Lymphomagenesis". Blood 122, n.º 21 (15 de noviembre de 2013): 4259. http://dx.doi.org/10.1182/blood.v122.21.4259.4259.
Texto completoHsieh, Y. T., C. Hubeau, V. Massa, W. LI, S. Frei, B. Capraro, A. Umana et al. "OP0316 EMERGING BEST-IN-CLASS IL-2 VARIANT HIGHLIGHTS TREG-DIRECTED THERAPY FOR AUTOIMMUNE DISEASE". Annals of the Rheumatic Diseases 79, Suppl 1 (junio de 2020): 195.1–195. http://dx.doi.org/10.1136/annrheumdis-2020-eular.1999.
Texto completoHarrington, Deirdre M., Sarahjane Belton, Tara Coppinger, Muireann Cullen, Alan Donnelly, Kieran Dowd, Teresa Keating et al. "Results from Ireland’s 2014 Report Card on Physical Activity in Children and Youth". Journal of Physical Activity and Health 11, s1 (enero de 2014): S63—S68. http://dx.doi.org/10.1123/jpah.2014-0166.
Texto completoRiley, Brigit E., Jeff Boonsripisal, Alicia Goodwin, Dominique Cartier, Eudean Garces, Kate Nesbitt, Courtney Dwyer et al. "Development of an Optimized rAAV2/6 Human Factor 8 cDNA Vector Cassette for Hemophilia a Gene Therapy". Blood 128, n.º 22 (2 de diciembre de 2016): 1173. http://dx.doi.org/10.1182/blood.v128.22.1173.1173.
Texto completoDias, Lizalynn, Venkata Thodima, Asha Guttapalli, Geetu Mendiratta, Sergei I. Syrbu y Jane Houldsworth. "Robust Assessment of Genomic Imbalance in Diffuse Large B-Cell Lymphoma Confirms Inferior Outcome Is Associated with Genomic Complexity and Identifies Potential Therapeutic Pathway Targets". Blood 124, n.º 21 (6 de diciembre de 2014): 2993. http://dx.doi.org/10.1182/blood.v124.21.2993.2993.
Texto completoAnguela, Xavier M., Rajiv Sharma, Yannick Doyon, Sunnie Y. Wong, David E. Paschon, Hojun Li, Virginia Haurigot et al. "In Vivo Genome Editing of Liver Albumin for Therapeutic Gene Expression: Rescue of Hemophilic Mice Via Integration of Factor 9". Blood 120, n.º 21 (16 de noviembre de 2012): 751. http://dx.doi.org/10.1182/blood.v120.21.751.751.
Texto completoTimmerman, John M., Kristopher K. Steward, Reiko E. Yamada, Patricia A. Young, Dena M. Minning, Raj K. Sachdev, Michael J. Gresser, Sanjay D. Khare y Sherie L. Morrison. "Antibody-Interferon-Alpha Fusion Protein Therapy for the Treatment of B-Cell Non-Hodgkin Lymphoma: Enhanced ADCC, Inhibition of Proliferation, and In Vivo Eradication of CD20+ Human Lymphomas". Blood 126, n.º 23 (3 de diciembre de 2015): 2762. http://dx.doi.org/10.1182/blood.v126.23.2762.2762.
Texto completoChekmasova, Alena A., Holly M. Horton, Tracy E. Garrett, John W. Evans, Johanna Griecci, Amanda Hamel, Howard J. Latimer et al. "A Novel and Highly Potent CAR T Cell Drug Product for Treatment of BCMA-Expressing Hematological Malignances". Blood 126, n.º 23 (3 de diciembre de 2015): 3094. http://dx.doi.org/10.1182/blood.v126.23.3094.3094.
Texto completoYounes, Anas, Connie Lee Batlevi, Jonathon B. Cohen, Sven de Vos, Daniel J. Landsburg, Zaw Win Myint, Krish Patel et al. "A Multi-Center Dose-Finding Study to Assess Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of Fimepinostat (CUDC-907) in Combination with Venetoclax in Patients with Relapsed/Refractory (R/R) Lymphoma". Blood 134, Supplement_1 (13 de noviembre de 2019): 4104. http://dx.doi.org/10.1182/blood-2019-128857.
Texto completoBjordahl, Ryan, Raedun Clarke, Svetlana Gaidarova, Brian Groff, Paul Rogers, Stacey Moreno, Ramzey Abujarour et al. "Off-the-Shelf Natural Killer Cell Immunotherapy for Enhanced Antibody Directed Cellular Cytotoxicity". Blood 128, n.º 22 (2 de diciembre de 2016): 3363. http://dx.doi.org/10.1182/blood.v128.22.3363.3363.
Texto completoSommer, Cesar, Hsin-Yuan Cheng, Yik Andy Yeung, Duy Nguyen, Janette Sutton, Zea Melton, Julien Valton et al. "Preclinical Evaluation of ALLO-819, an Allogeneic CAR T Cell Therapy Targeting FLT3 for the Treatment of Acute Myeloid Leukemia". Blood 134, Supplement_1 (13 de noviembre de 2019): 3921. http://dx.doi.org/10.1182/blood-2019-129025.
Texto completoRichon, Victoria M., Christopher J. Sneeringer, Margaret Porter Scott, Kevin W. Kuntz, Sarah K. Knutson, Roy M. Pollock y Robert A. Copeland. "Lymphoma-Associated Mutations of EZH2 Result In a Change-of-Function". Blood 116, n.º 21 (19 de noviembre de 2010): 707. http://dx.doi.org/10.1182/blood.v116.21.707.707.
Texto completoHuard, Justin, Laurie Tatalick, Carl Walkey y Ryan Swanson. "NL-201, a De Novo Agonist of IL-2 and IL-15 Receptors, Demonstrates Synergistic Antitumor Activity with Anti-PD-1 Checkpoint Inhibitor Therapy in a Preclinical Non-Hodgkin Lymphoma Model". Blood 138, Supplement 1 (5 de noviembre de 2021): 4560. http://dx.doi.org/10.1182/blood-2021-148885.
Texto completoGyurkocza, Boglarka, Rajneesh Nath, Patrick J. Stiff, Edward Agura, Mark Litzow, Ben Tomlinson, Hannah K. Choe et al. "Re-Induction and Targeted Conditioning with Anti-CD45 Iodine (131I) Apamistamab [Iomab-B] Leads to High Rates of Transplantation and Successful Engraftment in Older Patients with Active, Relapsed or Refractory (rel/ref) AML after Failure of Chemotherapy and Targeted Agents: Preliminary Midpoint Results from the Prospective, Randomized Phase 3 Sierra Trial". Blood 134, Supplement_1 (13 de noviembre de 2019): 5642. http://dx.doi.org/10.1182/blood-2019-122776.
Texto completoStorms, Robert W., Congxiao Liu, Elisabeth T. Tracy, Tracy Gentry, Andrew Balber y Joanne Kurtzberg. "ALDHbr Hematopoietic Progenitors Promote Short-Term Engraftment in Experimental Models for Cord Blood Transplantation." Blood 114, n.º 22 (20 de noviembre de 2009): 2433. http://dx.doi.org/10.1182/blood.v114.22.2433.2433.
Texto completoRosen, David B., James A. Cordeiro, David M. Soper, Ying-Wen Huang, Donna E. Hogge, Roland B. Walter, Alessandra Cesano y Wendy J. Fantl. "Distinct Signaling Profiles of Gemtuzumab Ozogamicin Responsiveness and Refractoriness in Acute Myeloid Leukemia." Blood 114, n.º 22 (20 de noviembre de 2009): 2745. http://dx.doi.org/10.1182/blood.v114.22.2745.2745.
Texto completoHowell, Stephen B., Hongying Zhang y William G. Rice. "A Phase 1a/b Dose Escalation Study of Apto-253 in Patients with Relapsed or Refractory AML or High-Risk MDS". Blood 134, Supplement_1 (13 de noviembre de 2019): 5148. http://dx.doi.org/10.1182/blood-2019-129685.
Texto completoSteen, Chloe B., Bogdan A. Luca, Mohammad Shahrokh Esfahani, Barzin Y. Nabet, Brian Sworder, Farshad Farshidfar, Kiarash Shamardani et al. "An Atlas of Clinically-Distinct Tumor Cellular Ecosystems in Diffuse Large B Cell Lymphoma". Blood 134, Supplement_1 (13 de noviembre de 2019): 655. http://dx.doi.org/10.1182/blood-2019-129461.
Texto completoStapleton, Ann, Aurelio Silvestroni, Pacita Roberts, Marsha Cox, Hillary Hayden, Mitchell Brittnacher, Samuel Miller y Thomas Hooton. "126. Robust and Persistent Vaginal Colonization with LACTIN-V Vaginal Lactobacillus crispatus Probiotic in a Double-Blind, Placebo-Controlled (DBPC) Phase 2b Trial to Prevent Recurrent UTI (rUTI)". Open Forum Infectious Diseases 5, suppl_1 (noviembre de 2018): S8. http://dx.doi.org/10.1093/ofid/ofy209.016.
Texto completoSmolen, J. S., F. Behrens, S. Liu Leage, C. Sapin, I. De La Torre, G. Meszaros, G. Schett et al. "AB0841 TARGET OUTCOMES IN PsA: SIMULTANEOUS ACHIEVEMENT of ACR50-PASI100 AND BEYOND: INSIGHTS FROM SPIRIT-H2H AT WEEK 24". Annals of the Rheumatic Diseases 79, Suppl 1 (junio de 2020): 1726.2–1727. http://dx.doi.org/10.1136/annrheumdis-2020-eular.2884.
Texto completoFang, Riguo, Yingchi Zhang, Pengfei Yuan, Huihui Yang, Lingling Yu, Yongjian Zhang, Jia Shi et al. "Highly Efficient Gene Editing of Human Hematopoietic Stem Cells to Treat X-Linked Sideroblastic Anemia". Blood 136, Supplement 1 (5 de noviembre de 2020): 1. http://dx.doi.org/10.1182/blood-2020-140208.
Texto completoLawrence, Jody, Nicholas Kitchin, Annaliesa S. Anderson, Michael W. Pride, Kathrin U. Jansen, William C. Gruber, Yahong Peng, Kevin Yi, Charles Knirsch y Chris Webber. "12. Randomized Studies of Two Clostridioides (Clostridium) difficile Vaccine Formulations". Open Forum Infectious Diseases 7, Supplement_1 (1 de octubre de 2020): S29. http://dx.doi.org/10.1093/ofid/ofaa439.057.
Texto completoLoveday, Kenneth, Doriana Froim, Anna Pisania, Alissa Fernald, Mathew Spaits, R. Scott Pearsall, Ravi Kumar y Kathryn W. Underwood. "ACE-536, a Novel GDF-Trap, Increases Hemoglobin, Hematocrit, and Red Blood Cell Levels in Rats and Monkeys." Blood 114, n.º 22 (20 de noviembre de 2009): 3603. http://dx.doi.org/10.1182/blood.v114.22.3603.3603.
Texto completoSrinivasan, Surabhi, Nguyen Tan, Hsin-Yuan Cheng, Yi Zhang, Silvia Tacheva-Grigorova, Tom Van Blarcom, Cesar Sommer, Duy Nguyen, Barbra Sasu y Siler Panowski. "Investigation of ALLO-316: A Fratricide-Resistant Allogeneic CAR T Targeting CD70 As a Potential Therapy for the Treatment of AML". Blood 136, Supplement 1 (5 de noviembre de 2020): 23. http://dx.doi.org/10.1182/blood-2020-142161.
Texto completoPeterson, James, Daniel Drazan, Hanna Czajka, Jason Maguire, Jean-Louis Pregaldien, Ilkka Seppa, Roger Maansson et al. "6. Pentavalent Meningococcal (MenABCWY) Vaccine is Safe and Well Tolerated With Immunogenicity Noninferior to Coadministered MenB-FHbp and MenACWY-CRM in a Phase 2 Study of Healthy Adolescents and Young Adults". Open Forum Infectious Diseases 7, Supplement_1 (1 de octubre de 2020): S25—S26. http://dx.doi.org/10.1093/ofid/ofaa439.051.
Texto completoSmith, Pascal, Evelyn Teh, Ken Chisholm, Susanne Penny, Devanand Pinto, Kelcey Patterson, Brennan Dirk et al. "Proteomic analysis of plasma exosomes as biomarkers of response to MVP-S based immunotherapy". Journal of Immunology 208, n.º 1_Supplement (1 de mayo de 2022): 66.09. http://dx.doi.org/10.4049/jimmunol.208.supp.66.09.
Texto completoCichocki, Frank, Ryan Bjordahl, Svetlana Gaidarova, Sajid Mahmood, Paul Rogers, Moyar Q. Ge, Dan S. Kaufman, Sarah Cooley, Bahram Valamehr y Jeffrey S. Miller. "iPSC-Derived NK Cells and Anti-PD-1 Antibody Synergize to Enhance T Cell Cytokine and Cytolytic Responses Against Multiple Tumors". Blood 132, Supplement 1 (29 de noviembre de 2018): 730. http://dx.doi.org/10.1182/blood-2018-99-114893.
Texto completoZinzani, Pier Luigi, Vladimir Melnichenko, Krimo Bouabdallah, Jan Walewski, Alejandro Majlis, Laura Fogliatto, Dolores Caballero et al. "Pembrolizumab Monotherapy in Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma (PMBCL): 3-Year Follow-up of the Keynote-170 Study". Blood 136, Supplement 1 (5 de noviembre de 2020): 42–43. http://dx.doi.org/10.1182/blood-2020-137080.
Texto completoNowakowski, Grzegorz, Annalisa Chiappella, Fangxin Hong, Randy D. Gascoyne, David W. Scott, William R. Macon, Rebecca L. King et al. "Potential Factors That Impact Lenalidomide/R-CHOP Efficacy in Previously Untreated Diffuse Large B-Cell Lymphoma in the ROBUST and ECOG-ACRIN 1412 Studies". Blood 134, Supplement_1 (13 de noviembre de 2019): 4092. http://dx.doi.org/10.1182/blood-2019-123083.
Texto completoMartinowitz, Uri, Amy D. Shapiro, Doris V. Quon, Miguel Antonio Escobar, Christine L. Kempton, Peter Collins, Pratima Chowdary et al. "Pharmacokinetic Behavior of IB1001, An Investigational Recombinant Factor IX, in Patients with Hemophilia B: Repeat Pharmacokinetic Study and Subgroup Analysis". Blood 118, n.º 21 (18 de noviembre de 2011): 2267. http://dx.doi.org/10.1182/blood.v118.21.2267.2267.
Texto completoKirsch, Ilan, Zijun Yidan Xu-Monette, Thomas Snyder y Ken H. Young. "Defining Immunoglobulin Somatic Hypermutation in De Novo Diffuse Large B-Cell Lymphoma Patients: Potential Application for Prognosis and Risk Stratification". Blood 124, n.º 21 (6 de diciembre de 2014): 1669. http://dx.doi.org/10.1182/blood.v124.21.1669.1669.
Texto completoMinson, Katherine A., Madeline G. Huey, Amanda A. Hill, Irene Perez, Xiaodong Wang, Stephen Frye, H. Shelton Earp, Deborah DeRyckere y Douglas K. Graham. "Bone Marrow Stromal Cell Mediated Resistance to Mertk Inhibition in Acute Leukemia". Blood 128, n.º 22 (2 de diciembre de 2016): 2819. http://dx.doi.org/10.1182/blood.v128.22.2819.2819.
Texto completo